1Laboratory of Ethnopharmacology, Institute for Nanobiomedical Technology and Membrane Biology, Regenerative Medicine Research Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China
2College of Mathematics, Sichuan University, Chengdu, China
3College of Light Industry, Textile and Food Engineering, Sichuan University, Chengdu, Sichuan, China
4Xinhua Hospital Attached to Dalian University, Department of Plastic Surgery, Dalian, Liaoning, China
Journal of Food and Nutrition Research.
2015,
Vol. 3 No. 6, 399-404
DOI: 10.12691/jfnr-3-6-7
Copyright © 2015 Science and Education PublishingCite this paper: Hai Niu, Limei Ma, Ke Li, Na Wang, Wen Huang. Geranyl Favonoid from Breadfruit Regulate Dyslipidemia in Hypercholesterolemic Rat.
Journal of Food and Nutrition Research. 2015; 3(6):399-404. doi: 10.12691/jfnr-3-6-7.
Correspondence to: Wen Huang, Laboratory of Ethnopharmacology, Institute for Nanobiomedical Technology and Membrane Biology, Regenerative Medicine Research Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China. Email:
niuhai@scu.edu.cn; huangwen@scu.edu.cnAbstract
Hpercholesterolemia is closely related to oxidative damages from high fat and cholesterol intakes. The geranyl flavonoid (GF) from Artocarpus altilis (Breadfruit) has potential antioxidant, anti-hyperlipidemia and anti-atherogenic properties. This work was to investigate the influence of GF on synthesis of cholesterol and lipogenesis in hypercholesterolemic rat fed with high-cholesterol diet. Treatment with GF significantly increased SOD, CAT, GPx and GR activities in organ tissues, as well as decreased TBARS activity compared to the untreated group. Total glutathione, NO and α-tocopherol contents in liver, kidney and adipose tissues in GF treated group were also higher than that in untreated group. In addition, the GF treatment increased ACAT and fatty acid synthase activities, and decreased HMG-CoA reductase activity. The results suggest that treatment of GF could inhibit the synthesis of cholesterol and the lipogenesis by regulating ACAT, HMG-CoA reductase and fatty acid synthase activities and improving the antioxidant defense status in hypercholesterolemic rat.
Keywords